Delhi HC sets aside Centre's ban on medicine 'Ace Proxyvon'
The Delhi High Court has set aside Centre's ban on Wockhardt's anti-inflammatory medicine 'Ace Proxyvon', used for painful rheumatic therapy. It was one of the 328 fixed dose combination (FDC) drugs banned by Centre in September 2018. Wockhardt filed a petition against the ban, arguing that it had not been provided with the report of the Drugs Technical Advisory Board.